vs
CUMBERLAND PHARMACEUTICALS INC(CPIX)与R F INDUSTRIES LTD(RFIL)财务数据对比。点击上方公司名可切换其他公司
R F INDUSTRIES LTD的季度营收约是CUMBERLAND PHARMACEUTICALS INC的1.7倍($22.7M vs $13.7M),R F INDUSTRIES LTD净利率更高(0.8% vs -10.3%,领先11.1%),CUMBERLAND PHARMACEUTICALS INC同比增速更快(31.1% vs 22.9%),R F INDUSTRIES LTD自由现金流更多($2.0M vs $3.0K),过去两年R F INDUSTRIES LTD的营收复合增速更高(29.8% vs 26.9%)
坎伯兰制药是一家专科制药企业,专注于开发、生产和商业化品牌处方药物,核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域,主要运营市场为美国,为相关医护人员与患者提供服务。
妥思卷工业是一家总部位于美国伊利诺伊州芝加哥的糖果制造商,旗下最知名的产品包括同名的Tootsie Roll软糖以及Tootsie Pop棒棒糖,目前其品牌产品销往加拿大、墨西哥等全球超过75个国家。
CPIX vs RFIL — 直观对比
营收规模更大
RFIL
是对方的1.7倍
$13.7M
营收增速更快
CPIX
高出8.1%
22.9%
净利率更高
RFIL
高出11.1%
-10.3%
自由现金流更多
RFIL
多$2.0M
$3.0K
两年增速更快
RFIL
近两年复合增速
26.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $13.7M | $22.7M |
| 净利润 | $-1.4M | $173.0K |
| 毛利率 | 83.6% | 36.8% |
| 营业利润率 | -10.0% | 4.0% |
| 净利率 | -10.3% | 0.8% |
| 营收同比 | 31.1% | 22.9% |
| 净利润同比 | 25.8% | 172.7% |
| 每股收益(稀释后) | $-0.09 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CPIX
RFIL
| Q4 25 | $13.7M | $22.7M | ||
| Q3 25 | $8.3M | $19.8M | ||
| Q2 25 | $10.8M | $18.9M | ||
| Q1 25 | $11.7M | $19.2M | ||
| Q4 24 | $10.4M | $18.5M | ||
| Q3 24 | $9.1M | $16.8M | ||
| Q2 24 | $9.8M | $16.1M | ||
| Q1 24 | $8.5M | $13.5M |
净利润
CPIX
RFIL
| Q4 25 | $-1.4M | $173.0K | ||
| Q3 25 | $-1.9M | $392.0K | ||
| Q2 25 | $-740.7K | $-245.0K | ||
| Q1 25 | $1.3M | $-245.0K | ||
| Q4 24 | $-1.9M | $-238.0K | ||
| Q3 24 | $-1.5M | $-705.0K | ||
| Q2 24 | $-1.1M | $-4.3M | ||
| Q1 24 | $-1.9M | $-1.4M |
毛利率
CPIX
RFIL
| Q4 25 | 83.6% | 36.8% | ||
| Q3 25 | 88.1% | 34.0% | ||
| Q2 25 | 81.4% | 31.5% | ||
| Q1 25 | 87.8% | 29.8% | ||
| Q4 24 | 81.1% | 31.3% | ||
| Q3 24 | 85.4% | 29.5% | ||
| Q2 24 | 82.6% | 29.9% | ||
| Q1 24 | 81.5% | 24.5% |
营业利润率
CPIX
RFIL
| Q4 25 | -10.0% | 4.0% | ||
| Q3 25 | -23.7% | 3.6% | ||
| Q2 25 | -6.9% | 0.6% | ||
| Q1 25 | 11.0% | 0.3% | ||
| Q4 24 | -17.7% | 0.5% | ||
| Q3 24 | -18.6% | -2.5% | ||
| Q2 24 | -10.4% | -2.6% | ||
| Q1 24 | -22.0% | -15.5% |
净利率
CPIX
RFIL
| Q4 25 | -10.3% | 0.8% | ||
| Q3 25 | -23.4% | 2.0% | ||
| Q2 25 | -6.8% | -1.3% | ||
| Q1 25 | 10.7% | -1.3% | ||
| Q4 24 | -18.2% | -1.3% | ||
| Q3 24 | -17.0% | -4.2% | ||
| Q2 24 | -11.0% | -26.7% | ||
| Q1 24 | -22.9% | -10.1% |
每股收益(稀释后)
CPIX
RFIL
| Q4 25 | $-0.09 | $0.01 | ||
| Q3 25 | $-0.13 | $0.04 | ||
| Q2 25 | $-0.05 | $-0.02 | ||
| Q1 25 | $0.08 | $-0.02 | ||
| Q4 24 | $-0.13 | $-0.02 | ||
| Q3 24 | $-0.11 | $-0.07 | ||
| Q2 24 | $-0.08 | $-0.41 | ||
| Q1 24 | $-0.14 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $5.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $35.2M |
| 总资产 | $76.8M | $73.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CPIX
RFIL
| Q4 25 | $11.4M | $5.1M | ||
| Q3 25 | $15.2M | $3.0M | ||
| Q2 25 | $16.1M | $3.6M | ||
| Q1 25 | $15.1M | $1.3M | ||
| Q4 24 | $18.0M | $839.0K | ||
| Q3 24 | $17.5M | $1.8M | ||
| Q2 24 | $17.3M | $1.4M | ||
| Q1 24 | $18.5M | $4.5M |
股东权益
CPIX
RFIL
| Q4 25 | $24.9M | $35.2M | ||
| Q3 25 | $26.1M | $34.8M | ||
| Q2 25 | $28.0M | $34.2M | ||
| Q1 25 | $28.7M | $34.2M | ||
| Q4 24 | $22.9M | $34.1M | ||
| Q3 24 | $24.8M | $34.1M | ||
| Q2 24 | $26.3M | $34.6M | ||
| Q1 24 | $27.5M | $38.7M |
总资产
CPIX
RFIL
| Q4 25 | $76.8M | $73.0M | ||
| Q3 25 | $65.9M | $73.2M | ||
| Q2 25 | $67.9M | $72.7M | ||
| Q1 25 | $69.9M | $70.4M | ||
| Q4 24 | $75.6M | $71.0M | ||
| Q3 24 | $76.7M | $71.9M | ||
| Q2 24 | $78.5M | $72.8M | ||
| Q1 24 | $81.5M | $79.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $3.0K | $2.1M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $2.0M |
| 自由现金流率自由现金流/营收 | 0.0% | 9.0% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 12.13× |
| 过去12个月自由现金流最近4个季度 | $4.8M | $4.3M |
8季度趋势,按日历期对齐
经营现金流
CPIX
RFIL
| Q4 25 | $3.0K | $2.1M | ||
| Q3 25 | $187.2K | $-311.0K | ||
| Q2 25 | $843.8K | $2.2M | ||
| Q1 25 | $3.9M | $601.0K | ||
| Q4 24 | $1.9M | $-244.0K | ||
| Q3 24 | $475.5K | $2.4M | ||
| Q2 24 | $-855.7K | $197.0K | ||
| Q1 24 | $-2.1M | $840.0K |
自由现金流
CPIX
RFIL
| Q4 25 | $3.0K | $2.0M | ||
| Q3 25 | $163.4K | $-419.0K | ||
| Q2 25 | $817.3K | $2.2M | ||
| Q1 25 | $3.9M | $574.0K | ||
| Q4 24 | $1.9M | $-418.0K | ||
| Q3 24 | $460.1K | $2.1M | ||
| Q2 24 | $-862.8K | $28.0K | ||
| Q1 24 | $-2.2M | $697.0K |
自由现金流率
CPIX
RFIL
| Q4 25 | 0.0% | 9.0% | ||
| Q3 25 | 2.0% | -2.1% | ||
| Q2 25 | 7.5% | 11.4% | ||
| Q1 25 | 32.9% | 3.0% | ||
| Q4 24 | 18.2% | -2.3% | ||
| Q3 24 | 5.1% | 12.6% | ||
| Q2 24 | -8.8% | 0.2% | ||
| Q1 24 | -25.6% | 5.2% |
资本支出强度
CPIX
RFIL
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.3% | 0.5% | ||
| Q2 25 | 0.2% | 0.2% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 0.0% | 0.9% | ||
| Q3 24 | 0.2% | 1.5% | ||
| Q2 24 | 0.1% | 1.0% | ||
| Q1 24 | 0.5% | 1.1% |
现金转化率
CPIX
RFIL
| Q4 25 | — | 12.13× | ||
| Q3 25 | — | -0.79× | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPIX
暂无分部数据
RFIL
| US | $20.9M | 92% |
| Non Us | $1.8M | 8% |